Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 5
1985 2
1986 1
1987 3
1988 3
1989 1
1990 2
1991 3
1992 1
1993 2
1994 2
1995 2
1996 5
1997 6
1998 2
2001 2
2003 8
2004 2
2005 4
2007 1
2010 11
2012 2
2014 2
2015 1
2016 1
2018 1
2019 1
2022 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. Among authors: klochikhin al. N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. N Engl J Med. 2025. PMID: 40532178 Clinical Trial.
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer.
Capdevila J, Klochikhin A, Leboulleux S, Isaev P, Badiu C, Robinson B, Hughes BGM, Keam B, Parnis F, Elisei R, Gajate P, Gan HK, Kapiteijn E, Locati L, Mangeshkar M, Faoro L, Krajewska J, Jarzab B. Capdevila J, et al. Among authors: klochikhin a. Thyroid. 2022 May;32(5):515-524. doi: 10.1089/thy.2022.0027. Thyroid. 2022. PMID: 35403447 Free PMC article. Clinical Trial.
[Pharyngeal rhabdomyosarcoma].
Klochikhin AL, Chistiakov AL, Rogozkin EN. Klochikhin AL, et al. Vestn Otorinolaringol. 2014;(5):59. Vestn Otorinolaringol. 2014. PMID: 25588488 Russian. No abstract available.
[Cancer of the thyroglossal duct].
Klochikhin AL, Byrikhina VV, Markov GI. Klochikhin AL, et al. Vestn Otorinolaringol. 2018;83(6):46-47. doi: 10.17116/otorino20188306146. Vestn Otorinolaringol. 2018. PMID: 30721183 Review. Russian.
[Chondrosarcoma of the trachea].
Bitiutskiĭ PG, Kislichko AG, Klochikhin AL. Bitiutskiĭ PG, et al. Among authors: klochikhin al. Vestn Otorinolaringol. 1987 Mar-Apr;(2):79-80. Vestn Otorinolaringol. 1987. PMID: 3590507 Russian. No abstract available.
[Use of a fiber light guide for the operating microscope].
Markov GI, Alekseĭchuk IV, Klochikhin AL. Markov GI, et al. Among authors: klochikhin al. Vestn Otorinolaringol. 1987 Sep-Oct;(5):67. Vestn Otorinolaringol. 1987. PMID: 3424520 Russian. No abstract available.
79 results